Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico

Clinical trial NCT04145856 · COMPLETED

Trial details

NCT number: NCT04145856
Sponsor: Hospital Juarez de Mexico
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2018-09-03
Primary completion: 2019-05-02
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.